(Q73536235)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233834%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Inducible antisense inhibition of erbB-2 expression reduces anchorage independent growth of ovarian carcinoma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233834%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

J C Pegues

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233834%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Stromberg

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233834%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233834%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233834%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233834%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233834%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

73-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233834%20AND%20SRC:MED&resulttype=core&format=json

Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

mRNA phenotyping of the major ligands and receptors of the EGF supergene family in human ovarian epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

Prevention of breast tumour development in vivo by downregulation of the p185neureceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

Inhibition of erbB-2-positive breast cancer cell growth by erbB-2 antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

Partial reversion of transformed phenotype of B104 cancer cells by antisense nucleic acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

Inhibition of the erbB-2 tyrosine kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900209-7

7 January 2021

10.1016/S0304-3835(97)00209-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233834%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference